Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/markets/deals/biogen-buy-human-immunology-biosciences-up-18-bln-deal-2024-05-22/

REUTERS
23 May 2024
FDA revises guidance on predicting Alzheimer's drug benefits
FDA revises guidance on predicting Alzheimer's drug benefits

12 Mar 2024

// Gabrielle Masson FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/new-fda-guidelines-consider-amyloid-reduction-reasonably-likely-predict-clinical-benefit

Gabrielle Masson FIERCE BIOTECH
12 Mar 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/biogen-discontinue-development-older-alzheimers-drug-aduhelm-2024-01-31/

REUTERS
01 Feb 2024
Biogen comes out ahead in Aduhelm-related investor lawsuit
Biogen comes out ahead in Aduhelm-related investor lawsuit

31 Mar 2023

// Zoey Becker FIERCE PHARMA

https://www.fiercepharma.com/pharma/biogen-scores-win-massachusetts-judge-dismisses-investor-lawsuit

Zoey Becker FIERCE PHARMA
31 Mar 2023

https://endpts.com/va-to-cover-eisais-new-alzheimers-drug-after-declining-to-cover-aduhelm/

Zachary Brennan ENDPTS
14 Mar 2023

https://www.fiercebiotech.com/biotech/dunn-fda-head-neuroscience-unit-depart

Max Bayer FIERCE BIOTECH
27 Feb 2023